164 related articles for article (PubMed ID: 16570508)
1. Thymidine phosphorylase from Escherichia coli: tight-binding inhibitors as enzyme active-site titrants.
Gbaj A; Edwards PN; Reigan P; Freeman S; Jaffar M; Douglas KT
J Enzyme Inhib Med Chem; 2006 Feb; 21(1):69-73. PubMed ID: 16570508
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening.
McNally VA; Gbaj A; Douglas KT; Stratford IJ; Jaffar M; Freeman S; Bryce RA
Bioorg Med Chem Lett; 2003 Nov; 13(21):3705-9. PubMed ID: 14552762
[TBL] [Abstract][Full Text] [Related]
3. Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides.
Fukushima M; Suzuki N; Emura T; Yano S; Kazuno H; Tada Y; Yamada Y; Asao T
Biochem Pharmacol; 2000 May; 59(10):1227-36. PubMed ID: 10736423
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.
Balzarini J; Degrève B; Esteban-Gamboa A; Esnouf R; De Clercq E; Engelborghs Y; Camarasa MJ; Pérez-Pérez MJ
FEBS Lett; 2000 Oct; 483(2-3):181-5. PubMed ID: 11042277
[TBL] [Abstract][Full Text] [Related]
5. Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.
Pérez-Pérez MJ; Priego EM; Hernández AI; Camarasa MJ; Balzarini J; Liekens S
Mini Rev Med Chem; 2005 Dec; 5(12):1113-23. PubMed ID: 16375757
[TBL] [Abstract][Full Text] [Related]
6. 8-Aza-7,9-dideazaxanthine acyclic nucleoside phosphonate inhibitors of thymidine phosphorylase.
Mařák D; Otmar M; Votruba I; Dračínský M; Krečmerová M
Bioorg Med Chem Lett; 2011 Jan; 21(2):652-4. PubMed ID: 21195612
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and molecular docking study of piperazine derivatives as potent inhibitor of thymidine phosphorylase.
Uddin I; Taha M; Rahim F; Wadood A
Bioorg Chem; 2018 Aug; 78():324-331. PubMed ID: 29626638
[TBL] [Abstract][Full Text] [Related]
8. Substrate specificity of Escherichia coli thymidine phosphorylase.
Panova NG; Alexeev CS; Kuzmichov AS; Shcheveleva EV; Gavryushov SA; Polyakov KM; Kritzyn AM; Mikhailov SN; Esipov RS; Miroshnikov AI
Biochemistry (Mosc); 2007 Jan; 72(1):21-8. PubMed ID: 17309433
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase.
Esteban-Gamboa A; Balzarini J; Esnouf R; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
J Med Chem; 2000 Mar; 43(5):971-83. PubMed ID: 10715161
[TBL] [Abstract][Full Text] [Related]
10. A similarity model for the human angiogenic factor, thymidine phosphorylase/platelet derived-endothelial cell growth factor.
Cole C; Marks DS; Jaffar M; Stratford IJ; Douglas KT; Freeman S
Anticancer Drug Des; 1999 Oct; 14(5):411-20. PubMed ID: 10766296
[TBL] [Abstract][Full Text] [Related]
11. Thymidine esters as substrate analogue inhibitors of angiogenic enzyme thymidine phosphorylase in vitro.
Javaid S; Ishtiaq M; Shaikh M; Hameed A; Choudhary MI
Bioorg Chem; 2017 Feb; 70():44-56. PubMed ID: 27955923
[TBL] [Abstract][Full Text] [Related]
12. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action.
Liekens S; Hernández AI; Ribatti D; De Clercq E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
J Biol Chem; 2004 Jul; 279(28):29598-605. PubMed ID: 15123637
[TBL] [Abstract][Full Text] [Related]
13. Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets.
Desgranges C; Razaka G; Rabaud M; Bricaud H; Balzarini J; De Clercq E
Biochem Pharmacol; 1983 Dec; 32(23):3583-90. PubMed ID: 6651877
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.
Murray PE; McNally VA; Lockyer SD; Williams KJ; Stratford IJ; Jaffar M; Freeman S
Bioorg Med Chem; 2002 Mar; 10(3):525-30. PubMed ID: 11814838
[TBL] [Abstract][Full Text] [Related]
15. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase.
Nencka R; Votruba I; Hrebabecký H; Tloust'ová E; Horská K; Masojídková M; Holý A
Bioorg Med Chem Lett; 2006 Mar; 16(5):1335-7. PubMed ID: 16337119
[TBL] [Abstract][Full Text] [Related]
17. 3'-Azidothymidine in the active site of Escherichia coli thymidine phosphorylase: the peculiarity of the binding on the basis of X-ray study.
Timofeev V; Abramchik Y; Zhukhlistova N; Muravieva T; Fateev I; Esipov R; Kuranova I
Acta Crystallogr D Biol Crystallogr; 2014 Apr; 70(Pt 4):1155-65. PubMed ID: 24699659
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).
Grierson JR; Brockenbrough JS; Rasey JS; Wiens L; Vesselle H
Nucleosides Nucleotides Nucleic Acids; 2010 Jan; 29(1):49-54. PubMed ID: 20391192
[TBL] [Abstract][Full Text] [Related]
19. 2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors.
Javaid S; Saad SM; Perveen S; Khan KM; Choudhary MI
Bioorg Chem; 2015 Dec; 63():142-51. PubMed ID: 26547232
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime)uracil derivatives as a new class of thymidine phosphorylase inhibitors.
Zhao S; Li K; Jin Y; Lin J
Eur J Med Chem; 2018 Jan; 144():41-51. PubMed ID: 29247859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
